gaap:ForeignExchangeContractMember
us-gaap:DesignatedAsHedgingInstrumentMember
amgn:AccruedLiabilitiesOtherNonCurrentLiabilitiesMember
2024-12-31
0000318154
amgn:CrossCurrencySwapContractsMember
us-gaap:DesignatedAsHedgingInstrumentMember
amgn:OtherCurrentNoncurrentAssetsMember
2024-12-31
0000318154
amgn:CrossCurrencySwapContractsMember
us-gaap:DesignatedAsHedgingInstrumentMember
amgn:AccruedLiabilitiesOtherNonCurrentLiabilitiesMember
2024-12-31
0000318154
us-gaap:InterestRateSwapMember
us-gaap:DesignatedAsHedgingInstrumentMember
amgn:OtherCurrentNoncurrentAssetsMember
2024-12-31
0000318154
us-gaap:InterestRateSwapMember
us-gaap:DesignatedAsHedgingInstrumentMember
amgn:AccruedLiabilitiesOtherNonCurrentLiabilitiesMember
2024-12-31
0000318154
us-gaap:DesignatedAsHedgingInstrumentMember
2024-12-31
0000318154
us-gaap:ForeignExchangeContractMember
us-gaap:DesignatedAsHedgingInstrumentMember
amgn:OtherCurrentNoncurrentAssetsMember
2023-12-31
0000318154
us-gaap:ForeignExchangeContractMember
us-gaap:DesignatedAsHedgingInstrumentMember
amgn:AccruedLiabilitiesOtherNonCurrentLiabilitiesMember
2023-12-31
0000318154
amgn:CrossCurrencySwapContractsMember
us-gaap:DesignatedAsHedgingInstrumentMember
amgn:OtherCurrentNoncurrentAssetsMember
2023-12-31
0000318154
amgn:CrossCurrencySwapContractsMember
us-gaap:DesignatedAsHedgingInstrumentMember
amgn:AccruedLiabilitiesOtherNonCurrentLiabilitiesMember
2023-12-31
0000318154
us-gaap:InterestRateSwapMember
us-gaap:DesignatedAsHedgingInstrumentMember
amgn:OtherCurrentNoncurrentAssetsMember
2023-12-31
0000318154
us-gaap:InterestRateSwapMember
us-gaap:DesignatedAsHedgingInstrumentMember
amgn:AccruedLiabilitiesOtherNonCurrentLiabilitiesMember
2023-12-31
0000318154
us-gaap:DesignatedAsHedgingInstrumentMember
2023-12-31
0000318154
amgn:AmgenInc.EtAl.V.CelltrionInc.EtAlMember
us-gaap:PendingLitigationMember
2024-05-28
0000318154
amgn:AmgenInc.EtAl.V.SamsungBioepisCo.Ltd.EtAlMember
us-gaap:PendingLitigationMember
2024-08-12
0000318154
amgn:AmgenInc.EtAl.V.FreseniusKabiUSALLCEtAlMember
us-gaap:PendingLitigationMember
2024-10-04
0000318154
amgn:AmgenInc.EtAl.V.AccordEtAlMember
us-gaap:PendingLitigationMember
2024-11-13
0000318154
amgn:PAVBLUPatentLitigationMember
us-gaap:PendingLitigationMember
2024-01-10
0000318154
amgn:PAVBLUPatentLitigationMember
us-gaap:PendingLitigationMember
2024-04-11
0000318154
amgn:SensiparAntitrustClassActionsMember
us-gaap:PendingLitigationMember
2019-02-01
2019-04-30
0000318154
amgn:SensiparAntitrustClassActionsMember
us-gaap:PendingLitigationMember
2022-03-11
0000318154
amgn:SensiparAntitrustClassActionsMember
us-gaap:PendingLitigationMember
2023-04-17
2023-04-17
0000318154
amgn:MartinDerivativeActionMember
us-gaap:PendingLitigationMember
2023-12-01
0000318154
amgn:ChemoCentryxIncSecuritiesMattersMember
2021-05-05
2021-06-08
0000318154
amgn:ChemoCentryxIncSecuritiesMattersMember
2024-05-02
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form
10-K
(Mark One)
For the fiscal year